Company / R&D per Share
Phibro Animal Health R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.59
FY2025
5-year range
$0.44 / $438.24
FY2021-FY2025
Trend
-18.7%
vs FY2024
Sector context
#172 of 208
Health Care
What the data says
Phibro Animal Health's r&d per share of $0.59 is lower than 83% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 10 years, ranging from $0.24 in FY2017 to $438.24 in FY2021.
Based on SEC 10-K filings.
0.59 in FY2025 with a 5-year CAGR of -72.0%.
Improved from $0.44 to $0.59 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +4.4%
- 5-Year CAGR
- -72.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 208This company $0.59 Sector average $12.19
▼
-95.2% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 18.7% year-over-year.
- Ranks #172 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2021.
- Lowest r&d per share in the period was in FY2017.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.59 | -18.7% |
| FY2024 | $0.72 | +64.4% |
| FY2023 | $0.44 | -14.8% |
| FY2022 | $0.51 | -99.9% |
| FY2021 | $438.24 | +28.8% |
| FY2020 | $340.18 | +14.0% |
| FY2019 | $298.42 | +8.1% |
| FY2018 | $275.99 | +116278.2% |
| FY2017 | $0.24 | -30.8% |
| FY2016 | $0.34 | -99.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026